Mohammad Hojat Farsangi
Dr Mohammad Hojjat-Farsangi has received his PhD in Medical Immunology and targeted Cancer Therapy from Tehran university of Medical Sciences, Tehran, Iran during the period of 2004-2009. Currently, he is working as assistant professor in Karolinska University, Stockholm, Sweden. He has successfully completed two Post-Doctoral periods on Targeted Based cancer Therapy with focus or ROR1 receptor tyrosine kinase. He is serving as an expert Reviewers for journals like Tumor Biology, Leukemia, Hepatitis Monthly, Human Vaccines & Immunotherapeutics and Medical Oncology. He authored more than 30 research and articles.
Tumor Biology, Leukemia, Hepatitis, Human Vaccines